A 12-week randomized controlled trial with 116 healthy adults showed EpiCor (500mg daily) reduced cold and flu symptoms by 21% compared to placebo. A separate 5-week study demonstrated increased natural killer cell activity and improved antioxidant status markers. Additional research in 45 adults found enhanced gut microbiome diversity and increased beneficial bacteria populations, though larger long-term studies are needed to confirm sustained immune benefits.

Origin
EpiCor is a whole food fermentate made from Saccharomyces cerevisiae, commonly known as baker's yeast. It is produced through a proprietary fermentation process.
Potential benefits
- Strengthens immune system by enhancing natural killer cell activity, reducing cold and flu symptoms by 21% in studies. - Supports gut health by promoting beneficial gut bacteria, improving digestion and nutrient absorption. - Increases antioxidant protection by boosting glutathione levels, reducing oxidative stress and cellular damage. - Enhances energy levels by optimizing mitochondrial function, leading to improved physical performance. - Reduces inflammation by modulating immune response, contributing to joint and muscle health. - Improves mood and cognitive function by increasing serotonin production, supporting mental clarity and focus. - Supports cardiovascular health by lowering cholesterol and improving blood vessel function.
How it works
EpiCor's beta-glucans bind to dectin-1 receptors on immune cells, activating complement pathways and enhancing natural killer cell cytotoxicity. The fermentate's mannooligosaccharides act as prebiotics, promoting Bifidobacterium and Lactobacillus growth while reducing pathogenic bacteria. Additionally, EpiCor increases glutathione peroxidase activity and stimulates secretory IgA production in mucosal tissues.
What the research says
Studies, including randomized controlled trials, have demonstrated EpiCor's ability to support immune health and maintain respiratory health during cold and flu season.
Safety and interactions
EpiCor is generally well-tolerated with mild gastrointestinal effects like bloating or gas reported in some users during initial weeks. No significant drug interactions have been documented, though individuals on immunosuppressive medications should consult healthcare providers. Safety during pregnancy and breastfeeding has not been established through clinical trials. People with yeast allergies should exercise caution, though the fermentation process typically reduces allergenic proteins.
Suggested use
Typical dosage is 500 mg per day. Consult a healthcare provider before use.
Frequently asked questions
How much EpiCor should I take daily?
The standard clinically studied dose of EpiCor is 500 mg per day. This dosage has been used in randomized controlled trials examining immune and respiratory health outcomes. EpiCor is typically taken as a single daily dose and is available in capsule or powder form. Because individual health needs vary, it is advisable to consult a healthcare provider before starting supplementation, particularly if you have underlying health conditions or are taking immunomodulatory medications.
Does EpiCor boost natural killer cell activity?
Yes. EpiCor contains beta-glucans that bind to dectin-1 receptors on immune cells, triggering complement pathway activation and directly enhancing natural killer (NK) cell cytotoxicity. NK cells are a critical first-line defence against virally infected and abnormal cells. By amplifying NK cell activity, EpiCor helps the immune system identify and eliminate threats more efficiently. This mechanism is supported by clinical research showing meaningful reductions in cold and flu symptom duration and severity with daily 500 mg supplementation.
Can EpiCor help with inflammation and joint pain?
EpiCor may help reduce inflammation through immune modulation rather than direct anti-inflammatory drug action. Its beta-glucans and fermentate metabolites help regulate immune response signalling, potentially lowering chronic low-grade inflammation that contributes to joint and muscle discomfort. Additionally, EpiCor's ability to boost glutathione peroxidase activity reduces oxidative stress, a key driver of inflammatory tissue damage. While promising, individuals with diagnosed inflammatory conditions should consult a healthcare provider before relying on EpiCor as a therapeutic intervention.
Is EpiCor safe to take long-term?
EpiCor has been evaluated in randomized controlled trials and demonstrates a favourable safety profile at 500 mg per day. As a dried Saccharomyces cerevisiae fermentate, it is derived from a well-established fermentation process and is generally well tolerated. No serious adverse effects have been reported in published studies. However, individuals with yeast allergies or compromised immune systems should exercise caution and seek medical advice before long-term use. As with any supplement, periodic reassessment with a healthcare provider is recommended.
Can I take EpiCor with probiotics?
Yes, EpiCor and probiotics are generally considered complementary. EpiCor's mannooligosaccharides act as prebiotics, selectively promoting the growth of beneficial bacteria such as Bifidobacterium and Lactobacillus, while suppressing pathogenic bacteria. Taking EpiCor alongside a probiotic supplement may create a synbiotic effect, where the prebiotic feeds and sustains the probiotic strains, potentially enhancing gut microbiome diversity and stability. No known negative interactions exist between EpiCor and common probiotic supplements.
Does EpiCor support mood and mental clarity?
Emerging evidence suggests EpiCor may support mood and cognitive function through its influence on serotonin production. The gut-brain axis connects microbiome health to neurotransmitter synthesis, and EpiCor's prebiotic effects on beneficial gut bacteria may support serotonin availability, which plays a role in mood regulation and mental focus. Additionally, by reducing oxidative stress via glutathione peroxidase stimulation, EpiCor may protect neuronal cells from cellular damage. These mechanisms are preliminary and should not replace clinically proven treatments for mood disorders.
References
- https://pubmed.ncbi.nlm.nih.gov/?term=epicor+saccharomyces+cerevisiae+fermentate
- https://pubmed.ncbi.nlm.nih.gov/38942887
This article is educational and is not medical advice. Statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before use.


